CMC Biologics has closed a share capital offering in connection with its acquisition of ICOS Biologics Manufacturing.

By:Diana Morgan

COPENHAGEN, Denmark , 28th February, 2008
CMC Biologics A/S (CMC, formerly CMC Biopharmaceuticals A/S) announced today that it has closed a share capital offering which was arranged as part of the Company’s financial strategy in connection with its recent acquisition of ICOS Biologics Manufacturing. Funds managed by Monitor Clipper Partners, LLC (MCP or Monitor Clipper) led the transaction, which also included follow-on investments from EEP and other existing investors. The financing round also provided liquidity for certain original shareholders of CMC. The financing will be employed for the development and build-out of ICOS Biologics Manufacturing facilities as well as for operational and working capital purposes.

Read the entire pdf press release.